Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Warfarin pharmacogenomics.

Cavallari LH, Limdi NA.

Curr Opin Mol Ther. 2009 Jun;11(3):243-51. Review.

PMID:
19479657
2.

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients.

Cho HJ, Sohn KH, Park HM, Lee KH, Choi B, Kim S, Kim JS, On YK, Chun MR, Kim HJ, Kim JW, Lee SY.

Pharmacogenomics. 2007 Apr;8(4):329-37.

PMID:
17391071
3.

Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.

Cavallari LH, Shin J, Perera MA.

Pharmacotherapy. 2011 Dec;31(12):1192-207. doi: 10.1592/phco.31.12.1192. Review.

4.

The largest prospective warfarin-treated cohort supports genetic forecasting.

Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori MJ, Bumpstead S, Holm L, McGinnis R, Rane A, Deloukas P.

Blood. 2009 Jan 22;113(4):784-92. doi: 10.1182/blood-2008-04-149070. Epub 2008 Jun 23. Erratum in: Blood. 2014 Feb 13;123(7):1113.

5.

Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients.

Cavallari LH, Butler C, Langaee TY, Wardak N, Patel SR, Viana MA, Shapiro NL, Nutescu EA.

Pharmacotherapy. 2011 Aug;31(8):785-92. doi: 10.1592/phco.31.8.785.

PMID:
21923605
6.

Does CALU SNP rs1043550 contribute variability to therapeutic warfarin dosing requirements?

Glurich I, Berg RL, Burmester JK.

Clin Med Res. 2013 Jun;11(2):73-9. doi: 10.3121/cmr.2013.1130. Epub 2013 May 8.

7.

Pharmacogenetics of warfarin.

Kamali F, Wynne H.

Annu Rev Med. 2010;61:63-75. doi: 10.1146/annurev.med.070808.170037. Review.

PMID:
19686083
8.

Pharmacogenetics of warfarin elimination and its clinical implications.

Takahashi H, Echizen H.

Clin Pharmacokinet. 2001;40(8):587-603. Review.

PMID:
11523725
9.

Reviews of Selected Pharmacogenetic Tests for Non-Cancer and Cancer Conditions [Internet].

Raman G, Trikalinos TA, Zintzaras E, Kitsios G, Ziogas D, Ip S, Lau J.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Nov 12.

10.

The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin.

Tabrizi AR, Zehnbauer BA, Borecki IB, McGrath SD, Buchman TG, Freeman BD.

J Am Coll Surg. 2002 Mar;194(3):267-73.

PMID:
11893129
11.

Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.

Gulseth MP, Grice GR, Dager WE.

Am J Health Syst Pharm. 2009 Jan 15;66(2):123-33. doi: 10.2146/ajhp080127. Review.

PMID:
19139476
12.

A PCR method for VKORC1 G-1639A and CYP2C9 A1075C genotyping useful to warfarin therapy among Japanese.

Tamura T, Katsuda N, Hamajima N.

Springerplus. 2014 Sep 5;3:499. doi: 10.1186/2193-1801-3-499. eCollection 2014.

13.
14.

Warfarin Therapy and the Genotypes CYP2C9 and VKORC1.

Dean L.

In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2012 Mar 8 [updated 2016 Jun 8].

15.

Warfarin dose requirements in a patient with the CYP2C9*14 allele.

Lee YM, Eggen J, Soni V, Drozda K, Nutescu EA, Cavallari LH.

Pharmacogenomics. 2014 May;15(7):909-14. doi: 10.2217/pgs.14.47.

16.

Pharmacogenomic Testing and Warfarin Management.

Maluso A.

Oncol Nurs Forum. 2015 Sep;42(5):563-5. doi: 10.1188/15.ONF.563-565.

PMID:
26302287
17.

Is personalized medicine a dream or a reality?

Morse BL, Kim RB.

Crit Rev Clin Lab Sci. 2015 Feb;52(1):1-11. doi: 10.3109/10408363.2014.950407. Epub 2014 Sep 2.

PMID:
25181036
18.

Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report.

LaSala A, Bower B, Windemuth A, White CM, Kocherla M, Seip R, Duconge J, RuaƱo G.

Conn Med. 2008 Aug;72(7):399-403. Erratum in: Conn Med. 2008 Oct;72(9):572.

19.

Warfarin pharmacogenomics.

Li J, Wang S, Barone J, Malone B.

P T. 2009 Aug;34(8):422-7.

20.

Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.

Daneshjou R, Gamazon ER, Burkley B, Cavallari LH, Johnson JA, Klein TE, Limdi N, Hillenmeyer S, Percha B, Karczewski KJ, Langaee T, Patel SR, Bustamante CD, Altman RB, Perera MA.

Blood. 2014 Oct 2;124(14):2298-305. doi: 10.1182/blood-2014-04-568436. Epub 2014 Jul 30.

Supplemental Content

Support Center